Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07282691 · ClinicalTrials.gov registry record
Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders
A clinical trial of mTBI - Mild Traumatic Brain Injury, sponsored by Salus University.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT07282691: Recruiting study of mTBI - Mild Traumatic Brain Injury, sponsored by Salus University.
NCT07282691 is a study of mTBI - Mild Traumatic Brain Injury that is actively recruiting participants, run by Salus University. The registered enrollment target is 150 participants, below the 206-participant average among 6 other mTBI - Mild Traumatic Brain Injury trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07282691, a study of mTBI - Mild Traumatic Brain Injury, is actively recruiting participants, sponsored by Salus University.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The specific aim of this project is to validate clinical tests to be used as outcome measures in studies of mTBI-related vision problems.
Primary Outcome
The ability to converge the eyes. A near point rod will be used with a 20/30 column of letters. The target will be moved towards the participant slowly, and when diplopia occurs, this will be recorded as the NPC break. The target will then be moved away from the eyes until single vision is regained, and this will be recorded as the NPC recovery. The unit of measure is cm and the NPC will be measured 3 times, with 10 seconds in between each measure, and averaged for each participant.
Conditions Studied
Study Locations (1)
Pennsylvania
- The Eye Institute - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2028-09-29 |
What NCT07282691 shows while recruiting
NCT07282691 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 206-participant average among 6 other mTBI - Mild Traumatic Brain Injury trials with a reported enrollment target (27% lower).
The record links to 1 condition, with mTBI - Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 0 interventions.
NCT07282691 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07282691 about?
NCT07282691 is a clinical study titled "Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders". The specific aim of this project is to validate clinical tests to be used as outcome measures in studies of mTBI-related vision problems.
What is the current status of trial NCT07282691?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-04-01. Estimated completion is 2028-09-29.
What conditions does trial NCT07282691 study?
This clinical trial studies the following conditions: mTBI - Mild Traumatic Brain Injury.
Who is sponsoring clinical trial NCT07282691?
This trial is sponsored by Salus University, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07282691 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for mTBI - Mild Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MindRhythm Detection of Concussion and Recovery Study
RECRUITING
-
Retraining Neural Pathways Improves Cognitive Skills After A Mild Traumatic Brain Injury
ACTIVE NOT RECRUITING · NA
-
Follow-up of MTBI Patients Discharged from the ED Using Standard Clinical Triage Including BrainScope One
ACTIVE NOT RECRUITING
-
Evaluation of Helmet Technology and Head Impact Exposure
COMPLETED · NA
-
Aerobic Exercise and Cognitive Training Effects on Postconcussive Symptomology
COMPLETED · NA
-
Live Video Mind-body Treatment to Prevent Persistent Symptoms Following mTBI
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI